Encompass Compliance Corp. (OTC: ENCC) News - May 4, 2017

Encompass Compliance Corporation (ENCC) selected by a major Lab - Announcement to be made at DATIA

CHARLOTTE, North Carolina, - May 4, 2017 /PRNewswire/ - Encompass Compliance Corp. (OTC: ENCC) has been selected by one of the largest drug testing laboratories (Labs) to provide real time industry updates and Risk Shield Services to their respective customers. The official announcement will be made at DATIA May 16-18th.

This Lab provides products and services to over 200,000 companies. It is important to both the Lab and their customers that state specific compliance services are provided to keep up with the rapidly changing legal landscape. Millions of employers use lab based drug testing for THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine, ecstasy, methadone, buprenorphine, barbiturates, to provide drug free workplaces. “Our offerings allow employers to properly follow state laws as they change and utilize our Risk Shield Service to update and maintain their compliance programs, for drug and alcohol testing in the workplace.” says Encompass CEO Richard Sharp

Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our solutions provide organizations with up to date policies, a comprehensive resource center and real-time monitoring for drug & alcohol testing orders.

There will be joint marketing activities such as webinars, industry seminars and real time alerts providing ongoing compliance services to these employers.

For further information, contact Richard Sharp at 866-328-7487 or admin@encompinc.com and https://www.encompinc.com/.

Safe Harbor Statement:
This press release may include predictions, estimates, opinions or statements that might be considered "forward-looking" under the provisions of the Private Securities Litigation Reform Act of 1995. Statements generally identified by phrases such as the Company or its management "believes," "expects," "forecasts," "estimates," or other words or phrases are forward-looking.
 

SOURCE Encompass Compliance Corp

__________________________________
Recent Encompass Compliance News:

Encompass Compliance Corporation (ENCC) Provides Services and Industry Knowledge to DATIA Members

CHARLOTTE, North Carolina, - April 11, 2017 /PRNewswire/ - Encompass Compliance Corp. (OTC: ENCC) signed an agreement that allows them to provide compliance services to DATIA members. On 16th-18th May, DATIA has its annual conference and Encompass Compliance Corp. will be a featured speaker focusing on the challenges and nuances for drug testing rules in the workplace.

The Drug and Alcohol Testing Industry Association (DATIA) was founded in 1995 and has grown to represent over 1,500 member companies. DATIA now represents the entire spectrum of drug and alcohol service providers including collection sites, laboratories, consortiums/TPAs, MROs, and testing equipment manufacturers.

DATIA provides a critical function to its members in the following areas:

They serve as the coordinated voice for the industry on regulatory and legislative matters of drug and alcohol testing and collection issues, as well as drug-free workplace regulatory issues.

They inform members, of issues affecting their businesses through newsletters, legislative alerts and meetings.

They collect and disseminate information on drug and alcohol service and product providers through a national directory distributed to businesses and the general public.

DATIA's members provide drug testing products and services to over 1,000,000 (million) corporations throughout the U.S. These members provide products that test for: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine, ecstasy, methadone, buprenorphine, barbiturates, ketamine, K2, tramadol, ETG. "Many of the major service and product suppliers to corporate America are members of DATIA. Therefore, we have a great audience to provide our Risk Shield Compliance services in support of our partner, DATIA," says Encompass CEO, Richard Sharp.

Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our solutions provide organizations with up to date policies, a comprehensive resource center and real-time monitoring for drug and alcohol testing orders.

Safe Harbor Statement:
This press release may include predictions, estimates, opinions or statements that might be considered "forward-looking" under the provisions of the Private Securities Litigation Reform Act of 1995. Statements generally identified by phrases such as the Company or its management "believes," "expects," "forecasts," "estimates," or other words or phrases are forward-looking.

For further information, contact:
Richard Sharp
+1-866-328-7487
admin@encompinc.com
URL: https://www.encompinc.com

SOURCE Encompass Compliance Corp

Encompass Compliance Corporation (ENCC) announces financial gains by a key customer

CHARLOTTE, North Carolina, - April 4, 2017 /PRNewswire/ - Encompass Compliance Corp. (OTC: ENCC) has compiled critical data of the savings, by a fortune 500 Customer that has over 100,000 employees in the U.S.

This respective company conducted a 6-state pilot implementing Encompass Compliance Corporation’s Risk Shield services and “the results were amazing,” the customer said. After just 6 months, the companies drug and alcohol claims were reduced 20%, resulting in a $6.5 million savings on claim pay outs. The results were so impressive they have decided to expand the program to more states. This was a post-accident only pilot testing for some key drugs such as: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine and ecstasy. “Compliance is key, but in addition to compliance you must aggressively pursue the benefits that exist for employers which can only be accomplished if state rules are followed. Helping our customers follow the rules is what we do.” says Encompass Co-Founder and CRO, Bill Judge.

Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our Risk Shield solution provides organizations with up to date policies, a comprehensive resource center and real-time monitoring for drug & alcohol testing orders.

For further information, contact Richard Sharp at 866-328-7487 or admin@encompinc.com and https://www.encompinc.com/.

Safe Harbor Statement:
This press release may include predictions, estimates, opinions or statements that might be considered "forward-looking" under the provisions of the Private Securities Litigation Reform Act of 1995. Statements generally identified by phrases such as the Company or its management "believes," "expects," "forecasts," "estimates," or other words or phrases are forward-looking.
 

For further information, contact
Richard Sharp
Phone: +1-866-328-7487
E-mail: admin@encompinc.com
https://www.encompinc.com/

SOURCE Encompass Compliance Corp.

Encompass Compliance Corporation (ENCC) has Pending Deals With Two of Three Largest Drug Testing Laboratories

CHARLOTTE, North Carolina, March 30, 2017 /PRNewswire/ - Encompass Compliance Corp. (OTC: ENCC) has been selected by two of the three largest drug testing laboratories (Labs), to provide Risk Shield Services and real time industry updates to their respective customers. These agreements are pending legal approval.

The Labs have recognized the need to provide state specific compliance services to their employer customers. These two Labs service between 500,000 and 1,000,000 (million) employers in the U.S. "Millions of employers use lab based drug testing for THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine, ecstasy, methadone, buprenorphine and barbiturates, to provide drug free workplaces. We will be providing the services that ensure employers are following the proper state laws when using these Lab services," says Encompass CEO Richard Sharp.

There will be joint marketing activities such as webinars, industry seminars and real time alerts, providing compliance services to these employers. More details of the execution of these relationships will follow.

About Encompass Compliance Corp.

Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our solutions provide organizations with up to date policies, a comprehensive resource center and real-time monitoring for drug & alcohol testing orders.

Safe Harbor Statement:
This press release may include predictions, estimates, opinions or statements that might be considered "forward-looking" under the provisions of the Private Securities Litigation Reform Act of 1995. Statements generally identified by phrases such as the Company or its management "believes," "expects," "forecasts," "estimates," or other words or phrases are forward-looking.

For further information, contact
Richard Sharp
Phone: +1-866-328-7487
E-mail: admin@encompinc.com
https://www.encompinc.com/

SOURCE Encompass Compliance Corp.

Encompass Compliance Corporation (ENCC) and Madison Avenue Drug Testing Sign a Channel Sales Agreement

CHARLOTTE, North Carolina, March 16, 2017 /PRNewswire/ - Encompass Compliance Corp. (OTC: ENCC) announces a channel sales agreement with Madison Avenue Drug Testing.

Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our solutions provide organizations with up-to-date policies, a comprehensive resource center and real-time monitoring for drug and alcohol testing orders.

Madison Avenue Drug Testing (http://madisonavenueproducts.com) is a premier provider of drug testing products to corporations throughout the U.S. They provide products that test for: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine, ecstasy, methadone, buprenorphine, barbiturates, ketamine, K2, tramadol, ETG. "As a supplier of drug testing products to over 3,000 companies, they are a natural fit to provide our Risk Shield Compliance services to their customers," says Encompass CEO, Richard Sharp.

Madison Avenue Drug Testing CEO Keith Devine says, "We feel extremely fortunate to be selected by Encompass Inc. as a channel partner. Combining the best legal minds in the business with our diverse clientele, instills confidence in our customers that they are provided the most comprehensive state specific compliance solutions available."

There will be joint marketing activities such as webinars, regular mailings and updates on a regular basis to Madison Avenue Drug Testing Customers.

Safe Harbor Statement:

This press release may include predictions, estimates, opinions or statements that might be considered "forward-looking" under the provisions of the Private Securities Litigation Reform Act of 1995. Statements generally identified by phrases such as the Company or its management "believes," "expects," "forecasts," "estimates," or other words or phrases are forward-looking.


For further information, contact:
Richard Sharp
866-328-7487
admin@encompinc.com
https://www.encompinc.com/
SOURCE Encompass Compliance Corp.

Encompass Compliance Corporation (ENCC) and i3screen Launch

CHARLOTTE, North Carolina, March 13, 2017 /PRNewswire/ - Encompass Compliance Corp. (OTC: ENCC) announces the integration of all three elements of our Risk Shield offering on the i3screen platform which was completed and launch in Q4 of 2016.

i3screen is an industry leader with more than 20,000 customers utilizing their technology through their partnerships, with over 200 Consumer Reporting Agencies (CRA), Third Party Administrators (TPA), and Medical Review Officers (MRO) nationwide. Potential customers large or small benefit from their fast and dependable employment screening services. Using industry expertise and advanced technology, their innovative solutions give employers the resources needed to implement best practice screening programs with the highest quality results.

Richard Sharp, Encompass' CEO, states, "This offering allows all customers on the i3screen platform to gain the benefit of the 3 elements of the Risk Shield Service: all i3screen customers can build compliant drug testing policies with the Policy Wizard, secondly, they now have the most comprehensive resource center designed for program managers to gain access to all elements of information pertaining to drug testing compliance and thirdly to ensure that tests are done properly and according to state law, at the time a test is ordered (which went live in June of 2016). Monthly releases will be provided to keep up with the ever-changing landscape of drug and alcohol testing laws.

Safe Harbor Statement:
This press release may include predictions, estimates, opinions or statements that might be considered "forward-looking" under the provisions of the Private Securities Litigation Reform Act of 1995. Statements generally identified by phrases such as the Company or its management "believes," "expects," "forecasts," "estimates," or other words or phrases are forward-looking.

For further information, contact Richard Sharp at 866-328-7487 or support@encompinc.com and https://www.encompinc.com/.
SOURCE Encompass Compliance Corp

Encompass Compliance Corporation (ENCC) Hires Schoonover as Chief Operating Officer

CHARLOTTE, North Carolina, June 20, 2016 /PRNewswire/ - Encompass Compliance Corp. (OTC: ENCC) announces that it has made an addition to its management team, hiring Mr. James Schoonover as its Chief Operating Officer.

James A. Schoonover, 59, comes to ENCC after a 16 year career with MEDTOX Scientific, which was sold to Laboratory Corporation of America in 2012. Schoonover has been involved in the drug and alcohol testing industry since 1987, having held both operating and marketing positions with companies involved in laboratory testing and specimen collection services.

Richard Sharp, CEO of Encompass, stated, "Jim Schoonover brings a very successful track record of growth and profitability to Encompass Compliance Corporation. His ability to profitably grow MEDTOX from $20 MM to $120 MM while providing clients with exceptional service was well recognized in the drug and alcohol testing industry. His public company experience will help Encompass, as we bring our new web-based compliance platform to market. I believe Jim will offer a fresh perspective and heightened communication capabilities to our valued shareholders."

Schoonover has an undergraduate degree from Cornell University in Ithaca, NY and an MBA from the University of St. Thomas in Minneapolis, MN.

About Encompass Compliance Corp.

Encompass Compliance Corp. is the most comprehensive provider of workplace drug, alcohol & marijuana compliance services. The company provides organizations with policies, procedures and training for supervisors and employees to manage their drug and alcohol testing programs. In addition Encompass provides claim defense services for your safety, risk and legal teams as well as information and content that supports your Human Resource and Drug Compliance Program Managers.

For additional information, view the company's website at www.encompinc.com and contact Mr. Richard Sharp at 866-328-7487 or admin@encompinc.com and https://www.encompinc.com/.

Forward-Looking Statements

Disclosures in this press release may contain forward-looking statements relating to anticipated or expected events, activities, trends or results. Such forward-looking statements, include, but are not limited to, statements regarding the results and cost of the test well, potential offsets, future drilling activities, and other statements that are not historical facts. Forward-looking statements, can be identified by the use of forward looking terminology such as "believes," "suggests," "expects," "may," "goal," "estimates," "should," "likelihood," "plans," "targets," "intends," "could," or "anticipates," or the negative thereof, or other variations thereon, or comparable terminology, or by discussions of strategy or objectives. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties. Such statements are made to provide the public with management's current assessment of the Company's business, and it should not be assumed that actual results will prove these statements to be correct. Security holders are cautioned that such forward-looking statements involve risks and uncertainties. Certain factors may cause results to differ materially from those anticipated by some of the statements made in this release.

Contact;
Richard Sharp
866-328-7487

https://www.encompinc.com/.
SOURCE Encompass Compliance Corp

-------------------------------------------------------------------
About Encompass Compliance Corp.:

WABOUT ENCOMPASS
Encompass Compliance Corp. is the industry's most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our solutions provide organizations with up to date policies, a comprehensive resource center and real-time monitoring for drug & alcohol testing orders.

RICHARD SHARP
Mr. Sharp is the co-founder and CEO of Encompass Inc. He is responsible for the creation and go to market strategy providing compliance and training solutions to Insurance Carriers and Insured organizations throughout the United States.

BILL JUDGE
Bill Judge is an attorney who, for the past 30 years, has concentrated his practice on research, consultation, litigation assistance, and management training related to the legal issues of substance abuse in the workplace and in our nation’s schools.

NICK HARTMAN
Nick Hartman is the VP of Channel Partners & Alliances. Nick is a very well networked thought leader and a recognized industry subject matter expert. He built an occupational health product & services division from scratch, with a SaaS company that emerged from a startup into an industry leader. Nick has consulted, implemented and managed drug-free workplace programs for 1000's of employers across the US and across the world.

JIM SCHOONOVER
Jim Schoonover was the Chief Marketing Officer at Medtox Scientific in Minneapolis for 16 years. He left MedTox when they were purchased by Laboratory Corporation of America (NYSE: LH). Schoonover was hired by Encompass Compliance Corporation in June, 2016 as their Chief Operating Officer. His track record of growing companies in a consistent, profitable manner will be beneficial to the company as it introduces a web-based compliance solutions platform to the drug and alcohol testing industry.

RISK SHIELD
Ready to get REAL compliance protection?
Compliance and regulatory issues are an obvious concern for companies performing drug and alcohol testing. Marijuana laws, mandatory state laws, ADA and OSHA issues, workers' compensation rules and required unemployment procedures impact every employer. No company has the time or expertise to keep up with all ongoing changes in the industry. Every employer needs an expert whose sole business is to stay current with these issues. Encompass is that company.

1. THE POLICY DEVELOPMENT WIZARD
Allows employers to quickly create a core drug & alcohol policy
Accounts for all current regulations (by state)
Immediately puts an employer’s policy in compliance

UNDERSTANDING THE BASICS
Every compliant workplace drug testing program should begin with a "Core" Company policy. Applicants and employees have a right to be informed of the specifics of the company’s drug and alcohol policy. The Encompass Policy Development Wizard will, by answering 7 specific questions, create a specific, detailed workplace drug and alcohol testing policy with all the related, up-to-date policy Addenda for state-specific rules.

The specific questions are basic and straightforward…

Company name (and logo if desired)
The state(s) in which the company operates
Who the company will test (employees/applicants)
Whether the company has union employees
Whether the company will test for alcohol
When the company will conduct tests (pre-employment, random, etc.)
What disciplines the company will enact in the event of a positive test
THE COMPLETE POLICY
The completed policy is very specific and is ready to be distributed (unless your company decides to review the policy with counsel). The sections of the policy include:

Statement of Policy
Applicability
Definitions
Notice to Applicants (and/or Employees)
Prohibited Substances
Testing Details
Collection of Samples/Lab Analysis
Alcohol Testing Procedures (if applicable)
Discipline/Appeal of Test Results
Review and Notice of Rights
Employee Education
Supervisory Training
Confidentiality
Appendix
A policy of this quality would cost thousands if a company were to hire a law firm or consulting company. Encompass brings it to our clients as part of our Risk Shield program.

2. RESOURCE CENTER
The world’s most complete resource on all aspects of drug & alcohol testing including marijuana laws, ADA, OSHA, workers' compensation & Unemployment issues
State-by-state “Compliance Kits” – an in-depth resource for company drug testing program managers

YOUR COMPREHENSIVE COMPLIANCE LIBARY
The Encompass Resource Center is the most complete, in-depth and accurate research library for any person looking to find information on drug and alcohol laws, regulations and court cases.

The core of the Resource Center is the State Compliance Kits, for all 50 states. These kits provide all the items needed to manage the compliance of your drug test program in any state. These kits are designed to be used in conjunction with your "core" company policy. Included in these kits are Employer’s State Compliance Guides, Post-Accident Checklists, Reasonable Suspicion Checklists, Implementation Checklists, Guides to State Laws on Marijuana, Mandatory State Statutes, Regulations and other topics critical to the successful management of company drug and alcohol testing programs.

Another important section in the Resource Center is the Common Issues Chart. This section gives you access to more than 20 documents that provide an overview on the issue described, such as states that limit random testing, adulteration issues, split specimen requirements, states that limit discipline and many, many more important topics.

How many employers would like a complete guide to marijuana in the workplace? The Resource Center has a specific category dealing with this issue organized by individual states.

3. REAL-TIME MONITORING
Provides an INSTANT compliance check
Audit on every drug test ordered
Validates the order is in compliance with state regulations

REAL TIME ORDERING COMPLIANCE & AUDITING
The Encompass Real Time Monitoring program is the first automated compliance verification system in the country. The program provides an instant “audit”, and user guidance, on every drug and alcohol test order as related to state legal responsibilities of the company. The Real Time Monitoring program is designed to protect employers by guiding choices to make certain they are in compliance with state/federal rules.

The system is very simple. On every order, the employer (or agent) enters three pieces of data:

The state where the applicant or employee resides
The specimen type being used for the test
The reason for the test
WHAT HAPPENS NEXT?
Once the information is loaded, the order goes through the monitoring process ‘instant audit’. A “green light” will appear on the ordering screen if the order is compliant. If a “red light” alert appears (detailing the applicable state or federal law, with a link to the appropriate regulatory information), this indicates that the order is non-compliant. A “yellow light” alert indicates there is additional information about state specific policies, procedures & adjudication actions related to the order, that the employer must consider.

The Real Time Monitoring program is especially beneficial to companies with locations in multiple states. If hiring is done at the local level and the person managing the hiring process is not knowledgeable about specific state laws and statutes, the Real Time Monitoring program becomes invaluable, by “auditing” each individual order, thereby mitigating the risks associated with non-compliant testing.

SOURCE: http://encompinc.com/

Disclaimer